Waldencast
10 Bank Street, Suite 560, White Plains, NY, 10606, United States
Overview
Waldencast is a holding company and investment fund that incubates and accelerates early stage beauty and wellness brands and helps them rapidly create scale and profitability via industry specific operational expertise. Waldencast invests in brand-led business models and goes beyond traditional incubation and acceleration to develop a collective of innovative and unique brands that place responsible entrepreneurship at the heart of its operations. Waldencast has offices in New York and London and has an investment portfolio in North America, Europe, and Latin America.
- Total investments
- 3
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 4
Sector focus
- Financial Services
- Incubators
- Venture Capital
Investment portfolio
- Revea
Participated · Equity · Apr 2022
Revea is a precision skincare company using advanced diagnostics, personal analysis, and machine learning to deliver skincare tailored to each individual's biology. The company was founded in 2020 by a team of skincare enthusiasts, biologists, and data scientists. Revea is based in San Francisco, CA. It recently closed a $6 million seed round. Investors named in the announcement include Alpha Edison, retailer Ulta Beauty, Waldencast Ventures, GISEV and Verlinvest, among others.
- Manual
Participated · Series A · Mar 2021
Manual began as an online seller of men’s health products but has since pivoted to focus on clinically-guided weight-loss treatments, concentrating on in-demand GLP-1 drugs like Ozempic and Mounjaro. The company offers telemedicine consultations, prescriptions and home delivery, positioning itself as a full-stack provider for obesity care. Management sees weight management as a massive, fast-growing market and plans to use data-driven marketing to reach new patient segments. CEO and co-founder George Pallis states that boosting brand awareness and customer acquisition are the primary near-term objectives. Manual’s recent funding allows it to invest aggressively in these marketing initiatives without immediate dilution or conventional debt service. Although no revenue or user figures were disclosed, the firm believes the new capital will accelerate its growth trajectory and help secure a leading share in the European GLP-1 market.
- The Nue Co.
Led · Series A · Jun 2019
The Nue Co develops personalised supplement formulas delivered via capsules, liquid meal supplements, and fragrance, sold through subscription plans. Its supplement plans are organised by categories including energy, gut health, immunity, skin, and sleep. The company says it takes a personalised approach to health by investing in data capture to understand customers’ bodies, guts, and sleep patterns. Jules Miller, founder and CEO, said the raise will allow the company to understand customers better and have a bigger impact through more efficient products and routines. The startup is British-founded, currently headquartered in the US, and counts the UK as its biggest market. The company raised funding to accelerate its personalised-product strategy.